Work

Abstract PO-009: AC676 a BTK Chimeric Degrader: Phase 1 study in patients with B-cell Malignancies

Year: 2024

Type: conference-abstract

Source: Blood Cancer Discovery

DOI: 10.1158/2643-3249.lymphoma24-po-009

Authors: Manish R Patel, Michael Tees, Farrukh T Awan, Nadia Khan, Nancy Mota, Hui Zhang, Su Young Kim, Jennifer Woyach

Institutions: Cancer Care Nova Scotia, Colorado Blood Cancer Institute, The University of Texas Southwestern Medical Center, Swedish Medical Center, The Ohio State University

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399815018

Cites:

Cited by: 4

Related to: 10